FISHER BIOIMAGE ApS: Financial statements 2019
CVR: 18683903
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
FISHER BIOIMAGE ApS (CVR 18683903) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -56,000 compared with DKK -61,000 the year before. Equity in the 2019 report amounted to DKK 721,128,000. The solvency ratio was 96.8%.
- Profit/Loss
- DKK -56,000
- Equity
- DKK 721,128,000
- Total Assets
- DKK 745,115,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -56K | 721.1M | - |
| 2018 | - | - | -61K | 721.2M | - |
| 2017 | - | -94K | -88K | 721.2M | - |
| 2016 | - | - | 933M | 721.3M | - |
| 2015 | - | - | -76K | 721.4M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of December 13, 2019, David Alan Laurie has joined the board of directors of FISHER BIOIMAGE ApS.
As of December 13, 2019, Linda Carina Carlsson has left the board of directors of FISHER BIOIMAGE ApS.
FISHER BIOIMAGE ApS has published its annual report for 2018. The net result was DKK -61,000.
About FISHER BIOIMAGE ApS
FISHER BIOIMAGE ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 1995. The company has been dissolved on 6 December 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named APOGENT HOLDINGS ApS and APOGENT HOLDINGS A/S. The company has 0 employees (2009). In 2020, the company reported a gross profit of DKK -57,000 and a net result of DKK -60,000 compared with DKK -56,000 the year before. Equity in the 2020 report amounted to DKK 721,068,000.